Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT05494892 Completed - Clinical trials for Conditions Influencing Health Status

Development of a Research Agenda for Rehabilitation Research

Start date: April 1, 2021
Phase:
Study type: Observational

An internal research department was established in the course of an organisational reform of the Pension Insurance Institution in 2020 for the evidence-based development of its own services in Austria. The focus is on the transfer of findings into practice and the scientific community. As part of an initial assessment of the current situation, an organisation-specific research agenda is being systematically developed. The project design is based on a multi-perspective and multi-method approach. After obtaining experts' opinions (interview) from different settings and areas, a consensus on necessary fields of action will be worked out after synthesising the results via a Delphi survey.

NCT ID: NCT05493826 Completed - Clinical trials for Cutaneous Squamous Cell Carcinoma

Real World Study on the Use of Cemiplimab in Adult Patients in UK

REACT-CEMI
Start date: July 18, 2022
Phase:
Study type: Observational

The primary objective is to describe the real-world clinical effectiveness of cemiplimab in patients with locally advanced cutaneous squamous cell carcinoma (laCSCC) or metastatic cutaneous squamous cell carcinoma (mCSCC) treated in routine clinical practice.

NCT ID: NCT05493540 Completed - Clinical trials for Patent Ductus Arteriosus After Premature Birth

Oral Ibuprofen Versus Placebo in Treatment of Patent Ductus Arteriosus (PDA)in Preterm Infants

Start date: April 15, 2021
Phase: Phase 2
Study type: Interventional

The management options of Patent Ductus Arteriosus are still controversial and differ between centers. Recently, conservative management has been gaining interest as the evidence of benefit from medical treatment in terms of mortality and morbidity is lacking. This study will compare oral ibuprofen (the standard treatment) with the conservative treatment, in terms of ductal closure and morbidity and mortality at discharge in preterm neonates less than 34 weeks.

NCT ID: NCT05492409 Completed - Clinical trials for Idiopathic Thrombocytopenic Purpura

Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients

Start date: March 28, 2022
Phase: Phase 3
Study type: Interventional

It is a phase III extension study to assess safety and immunogenicity of long-term therapy with GNR-069 in patients with idiopathic thrombocytopenic purpura

NCT ID: NCT05491967 Completed - Clinical trials for Obstructive Sleep Apnea/Hypopnea Syndrome

Comparison of Vascular Risk in Patients Treated for Obstructive Sleep Apnea/Hypopnea Syndrome

SAHOSVAS
Start date: March 16, 2021
Phase:
Study type: Observational

a monocentric,non interventional, prospective study to compare cardiovascular risk in patients with Obstructive Sleep Apnea/Hypopnea Syndrome treated with Continuous Positive Airway Pressure (CPAP) and Mandibular Advancement Orthosis.

NCT ID: NCT05490017 Completed - Clinical trials for Paroxysmal Nocturnal Hemoglobinuria

To Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating Single and Multiple Doses of KP104

Start date: December 30, 2020
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate safety, tolerability, immunogenicity, pharmacokinetics, pharmacodynamics, and efficacy of KP104 in healthy volunteers. The study will be conducted in 2 parts: Part 1, the single ascending dose (SAD) is the first in human (FIH) study of KP104 and Part 2, multiple ascending dose (MAD).

NCT ID: NCT05489796 Completed - Clinical trials for Laparoscopic Gynecological Surgery

Bellomic PCA in Laparoscopic Gynecologic Surgery

Start date: June 30, 2022
Phase: N/A
Study type: Interventional

In laparoscopic gynecological surgery, when intravenous patient-controlled analgesia (IV-PCA) device is used after surgery, the degree of postoperative side effects and pain control is compared when a combination of fentanyl and ketorolac is administered compared to when fentanyl alone is used.

NCT ID: NCT05488925 Completed - Clinical trials for Symptomatic Irreversible Pulpitis

Comparison of Preoperative Analgesics on the Efficacy of Inferior Alveolar Nerve Block.

Start date: June 21, 2021
Phase: Phase 4
Study type: Interventional

The purpose of this study is to see how preoperative oral diclofenac sodium, piroxicam, and tramadol affects inferior alveolar nerve block efficacy during root canal treatment of mandibular molars with symptomatic irreversible pulpitis. The proposed hypothesis is that the tested drug groups will improve the efficacy of inferior alveolar nerve block in comparison to the control group.

NCT ID: NCT05485259 Completed - Clinical trials for Low-Grade Squamous Intraepithelial Lesions

Effect of Alpha-lipoic Acid on Regression of Low-grade Squamous Intraepithelial Lesions (LSIL)

Start date: January 15, 2020
Phase: N/A
Study type: Interventional

Low-grade squamous intraepithelial lesions (LSIL) are premalignant changes on the cervix that can lead to malignant changes, i. e. cervical cancer. Alpha-lipoic acid is a fatty acid that is naturally found in food, and due to its proven antioxidant and anti-inflammatory effects, it is increasingly used as a dietary supplement, most often to alleviate the symptoms of various neuropathic conditions. The purpose of this study was to demonstrate efficiency, safety, and clinical benefit of alpha lipoic acid (ALA) in inducing regression of LSIL. The hypothesis is based on the proven role of oxidative stress and inflammation in formation of LSIL and anti-inflammatory and antioxidative efficiency of ALA. The study was designed as randomized, double-blind, two-arm, placebo-control trial recruiting 100 female patients with diagnosed LSIL. Patients received 600 mg/day of ALA or placebo for 3 months. Progression/regression of LSIL has been defined as primary outcome of the study; inflammation markers and oxidative stress parameters have been defined as secondary outcomes of the study.

NCT ID: NCT05485051 Completed - Clinical trials for Ventilator Associated Pneumonia

Daily Chlorexidine Bath for Health Care Associated Infection Prevention

CLEAN-IT
Start date: August 3, 2022
Phase: Phase 3
Study type: Interventional

Cluster randomized controlled trial comparing two bathing strategies in critically ill patients. The intervention group will receive daily bathing with chlorhexidine. The control group will receive usual care.